Methotrexate and Prednicarbate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methotrexate (methotrexate sodium) and Prednicarbate (prednicarbate). Common drug interactions include haemangioma among females and coronary artery occlusion among males.

The phase IV clinical study analyzes what interactions people have when they take Methotrexate and Prednicarbate. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,312 Methotrexate users. Check the latest studies of Methotrexate.

What is Prednicarbate?

Prednicarbate has active ingredients of prednicarbate. eHealthMe is studying from 298 Prednicarbate users. Check the latest studies of Prednicarbate.

On Jul, 07, 2026

12 people who take Methotrexate and Prednicarbate together, and have interactions are studied.

Methotrexate and Prednicarbate drug interactions.

What are the common drug interactions of Methotrexate and Prednicarbate, by gender? *:

female:

Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Haematuria (presence of blood in urine)
Hepatic enzyme increased
Infection
Infusion related reaction
Pityriasis rubra pilaris (reddish-orange colour scaling patches with well defined borders)
Respiratory failure (inadequate gas exchange by the respiratory system)
Spleen disorder (disease of spleen)
Intraductal papillary mucinous neoplasm (tumour (neoplasm) that grows within the pancreatic ducts)
Fibromyalgia (a long-term condition which causes pain all over the body)

male:

Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Fatigue (feeling of tiredness)
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Tuberculin test positive

What are the common drug interactions of Methotrexate and Prednicarbate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fibromyalgia (a long-term condition which causes pain all over the body)
Cough
Haemangioma (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Haematuria (presence of blood in urine)
Infection
Infusion related reaction
Spleen disorder (disease of spleen)

40-49:

Tuberculin test positive
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Fatigue (feeling of tiredness)
Migraine (headache)
Nausea (feeling of having an urge to vomit)

50-59:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Respiratory failure (inadequate gas exchange by the respiratory system)

60+:

Intraductal papillary mucinous neoplasm (tumour (neoplasm) that grows within the pancreatic ducts)
Drug ineffective
Hepatic enzyme increased
Pityriasis rubra pilaris (reddish-orange colour scaling patches with well defined borders)

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 50.00%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 6 people, 50.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 25.00%
Depression: 3 people, 25.00%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 25.00%
High Blood Pressure: 3 people, 25.00%
Weight Loss: 2 people, 16.67%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 16.67%
Dyslipidaemia (abnormal amount of lipids): 2 people, 16.67%
Amaurosis Fugax (painless transient monocular visual loss): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate and Prednicarbate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously